108 related articles for article (PubMed ID: 14982826)
1. Azithromycin and bronchiolitis obliterans.
Kanazawa S; Nomura S; Muramatsu M; Yamaguchi K; Fukuhara S
Am J Respir Crit Care Med; 2004 Mar; 169(5):654-5; author reply 655. PubMed ID: 14982826
[No Abstract] [Full Text] [Related]
2. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study.
Gerhardt SG; McDyer JF; Girgis RE; Conte JV; Yang SC; Orens JB
Am J Respir Crit Care Med; 2003 Jul; 168(1):121-5. PubMed ID: 12672648
[TBL] [Abstract][Full Text] [Related]
3. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.
Vanaudenaerde BM; Meyts I; Vos R; Geudens N; De Wever W; Verbeken EK; Van Raemdonck DE; Dupont LJ; Verleden GM
Eur Respir J; 2008 Oct; 32(4):832-43. PubMed ID: 18827151
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome.
Verleden GM; Vanaudenaerde BM; Dupont LJ; Van Raemdonck DE
Am J Respir Crit Care Med; 2006 Sep; 174(5):566-70. PubMed ID: 16741151
[TBL] [Abstract][Full Text] [Related]
5. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
[TBL] [Abstract][Full Text] [Related]
6. Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis.
Kingah PL; Muma G; Soubani A
Clin Transplant; 2014 Aug; 28(8):906-10. PubMed ID: 24931185
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin and bronchiolitis obliterans syndrome after lung transplantation: is prevention better than cure?
Fisher AJ
Eur Respir J; 2011 Jan; 37(1):10-2. PubMed ID: 21205711
[No Abstract] [Full Text] [Related]
8. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study.
Khalid M; Al Saghir A; Saleemi S; Al Dammas S; Zeitouni M; Al Mobeireek A; Chaudhry N; Sahovic E
Eur Respir J; 2005 Mar; 25(3):490-3. PubMed ID: 15738293
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.
Vos R; Vanaudenaerde BM; Verleden SE; Ruttens D; Vaneylen A; Van Raemdonck DE; Dupont LJ; Verleden GM
Transplantation; 2012 Jul; 94(2):101-9. PubMed ID: 22461039
[TBL] [Abstract][Full Text] [Related]
10. A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation.
Corris PA; Ryan VA; Small T; Lordan J; Fisher AJ; Meachery G; Johnson G; Ward C
Thorax; 2015 May; 70(5):442-50. PubMed ID: 25714615
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin in posttransplant bronchiolitis obliterans syndrome.
Vos R; Vanaudenaerde BM; Verleden SE; Van Raemdonck DE; Dupont LJ; Verleden GM
Chest; 2011 May; 139(5):1246. PubMed ID: 21540223
[No Abstract] [Full Text] [Related]
12. Obliterative bronchiolitis following lung transplantation: from old to new concepts?
Verleden GM; Vos R; De Vleeschauwer SI; Willems-Widyastuti A; Verleden SE; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
Transpl Int; 2009 Aug; 22(8):771-9. PubMed ID: 19490538
[TBL] [Abstract][Full Text] [Related]
13. Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer?
Vos R; Vanaudenaerde BM; Ottevaere A; Verleden SE; De Vleeschauwer SI; Willems-Widyastuti A; Wauters S; Van Raemdonck DE; Nawrot TS; Dupont LJ; Verleden GM
J Heart Lung Transplant; 2010 Dec; 29(12):1358-68. PubMed ID: 20619683
[TBL] [Abstract][Full Text] [Related]
14. Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans.
Krenn K; Gmeiner M; Paulus P; Sela N; Torres L; Zins K; Dekan G; Aharinejad S
J Thorac Cardiovasc Surg; 2015 Apr; 149(4):1194-202. PubMed ID: 25595376
[TBL] [Abstract][Full Text] [Related]
15. Lung transplantation: the role of azithromycin in the management of patients with bronchiolitis obliterans syndrome.
Fietta AM; Meloni F
Curr Med Chem; 2008; 15(7):716-23. PubMed ID: 18336286
[TBL] [Abstract][Full Text] [Related]
16. Administration of anti-interleukin-2Ralpha monoclonal antibody in bronchiolitis obliterans syndrome after lung transplantation.
Ding IB; Baumgartner RA; Schwaiblmair M; Behr J
Transplantation; 2003 May; 75(10):1767-9. PubMed ID: 12777880
[No Abstract] [Full Text] [Related]
17. Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients.
Shitrit D; Bendayan D; Gidon S; Saute M; Bakal I; Kramer MR
J Heart Lung Transplant; 2005 Sep; 24(9):1440-3. PubMed ID: 16143268
[TBL] [Abstract][Full Text] [Related]
18. Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated?
Bryant DH
Eur Respir J; 2005 Mar; 25(3):402-4. PubMed ID: 15738280
[No Abstract] [Full Text] [Related]
19. Targeting allograft injury and inflammation in the management of post-lung transplant bronchiolitis obliterans syndrome.
Robertson AG; Griffin SM; Murphy DM; Pearson JP; Forrest IA; Dark JH; Corris PA; Ward C
Am J Transplant; 2009 Jun; 9(6):1272-8. PubMed ID: 19459806
[TBL] [Abstract][Full Text] [Related]
20. [Azithromycin as a novel treatment for bronchiolitis obliterans syndrome].
Peled N; Shitrit D; Bendayan D; Kramer MR
Harefuah; 2007 Mar; 146(3):219-22, 245. PubMed ID: 17460931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
